Skip Navigation


European Heart Journal Advance Access originally published online on February 15, 2005
European Heart Journal 2005 26(6):544-548; doi:10.1093/eurheartj/ehi149
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/6/544    most recent
ehi149v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McClelland, A. J.J.
Right arrow Articles by Adgey, A.A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McClelland, A. J.J.
Right arrow Articles by Adgey, A.A. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Percutaneous coronary intervention and 1 year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction

Anthony J.J. McClelland1, Colum G. Owens1, Simon J. Walsh1, David McCarty1, Thomas Mathew2, Mike Stevenson3, Helen Gracey1, Mazhar M. Khan1 and A.A. Jennifer Adgey1,*

1Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, Ireland
2United Hospitals, Antrim, Ireland
3Queen's University, Belfast, Ireland

Received 9 September 2004; revised 22 December 2004; accepted 29 December 2004; online publish-ahead-of-print 15 February 2005.

* Corresponding author. Tel: +44 2890 633223/632171; fax: +44 2890 312907. E-mail address: jennifer.adgey{at}royalhospitals.n-i.nhs.uk

See page 529 for the editorial comment on this article (doi:10.1093/eurheartj/ehi126)

Aims To assess the predictors of 1 year mortality in patients treated with fibrinolytic therapy for ST-segment elevation myocardial infarction (STEMI) and to determine whether a strategy of early percutaneous coronary intervention (PCI) improves outcome.

Methods and results Consecutive patients (n=474) admitted to our unit (1998–2001) with STEMI were treated with fibrinolytic therapy. For each patient, age, gender, admission via mobile coronary care unit (MCCU), infarct location, initial systolic blood pressure and Killip class, prior history of ischaemic heart disease, hypertension, diabetes mellitus, smoking status, family history, hyperlipidaemia, and in-hospital PCI (n=154) were recorded. Mortality at 1 year was obtained from medical records (n=473). Binary logistic regression analysis was performed to determine independent predictors of 1 year mortality. Mortality in the non-PCI group was 21 vs. 7% in the PCI group. Independent predictors of 1 year mortality were age (risk ratio 1.12, 95% CI 1.08–1.15, P<0.0001), initial SBP≤80 mmHg (risk ratio 4.34, 95% CI 1.68–11.2, P=0.002), initial Killip class ≥3 (risk ratio 2.97, 95% CI 1.42–6.2, P=0.004), and lack of in-hospital PCI (risk ratio 0.39, 95% CI 0.19–0.81, P=0.012). Although the PCI group were younger (P=0.007), more likely to be admitted via the MCCU (P=0.008), with a shorter pain to needle time (P=0.04), multivariable analysis adjusted for these differences.

Conclusion In-hospital PCI in patients treated with fibrinolytic therapy for STEMI is associated with a substantial reduction in 1 year mortality.

Key Words: ST-elevation myocardial infarction • Primary percutaneous coronary intervention • Fibrinolytic therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must?
Nicolas Danchin
EHJ 2005 26: 529-531. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart J SupplHome page
C. Bode and K. Huber
Antiplatelet therapy in percutaneous coronary intervention
Eur. Heart J. Suppl., January 1, 2008; 10(suppl_A): A13 - A20.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
F. Osman, S. Qaisar, and N. El Gaylani
Limitations of the study evaluating fibrinolytic therapy and in-hospital PCI for ST-elevation myocardial infarction
Eur. Heart J., August 2, 2005; 26(16): 1684 - 1684.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A.A. J. Adgey and A. J.J. McClelland
Percutaneous coronary intervention and 1-year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction: reply
Eur. Heart J., August 2, 2005; 26(16): 1684 - 1685.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
N. Danchin
Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must?
Eur. Heart J., March 2, 2005; 26(6): 529 - 531.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.